Form 4 for NMTC NEUROONE MEDICAL TECHNOLOGIES Corp
Accepted 2026-03-03 00:00:00 ET · period of report 2026-03-01 · accession 0001971798-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-03 | 2026-03-01 | NMTC | Wambeke David J. | Chief Business Off | P - Purchase | $0.67 | +1.00M | 1.00M | New | +$670.0K |
| D | 2026-03-03 | 2026-03-01 | NMTC | Wambeke David J. | Chief Business Off | A - Grant | $0.00 | +500.0K | 500.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-01 | P | A | 1,000,000 | $0.67 | 1,000,000 | D | — | — | |
| 2 | Derivative | Option to Purchase Common Stock | 2026-03-01 | A | A | 500,000 | $0.00 | 500,000 | D | $0.67 · — to 2036-02-29 | 500,000 Common Stock | (F1) 25% will vest on March 1, 2027, and the remaining 75% will vest in 12 equal installments on the last day of each quarter beginning on March 31, 2027. |